Video

Key Publications on NACT and Targeted therapies in head and neck cancer

Results of a randomized phase III study of Nimotuzumab in combination with concurrent radiotherapy and Cisplatin versus radiotherapy and Cisplatin alone, in locally advanced sq uamous cell carcinoma of the head and neck

Chairpersons :

Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath

Reviewer :

Vijay Patil